CETP levels rather than polymorphisms as markers of coronary risk: healthy athlete with high HDL-C and coronary disease--effectiveness of probucol

Atherosclerosis. 2006 May;186(1):225-7. doi: 10.1016/j.atherosclerosis.2006.02.024. Epub 2006 Mar 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anticholesteremic Agents / therapeutic use
  • Carrier Proteins / blood
  • Carrier Proteins / genetics*
  • Cholesterol Ester Transfer Proteins
  • Cholesterol, HDL / blood*
  • Coronary Disease / blood*
  • Coronary Disease / drug therapy
  • Coronary Disease / genetics
  • DNA / genetics*
  • Genetic Predisposition to Disease
  • Glycoproteins / blood
  • Glycoproteins / genetics*
  • Humans
  • Male
  • Polymorphism, Genetic*
  • Probucol / therapeutic use*
  • Sports*

Substances

  • Anticholesteremic Agents
  • CETP protein, human
  • Carrier Proteins
  • Cholesterol Ester Transfer Proteins
  • Cholesterol, HDL
  • Glycoproteins
  • DNA
  • Probucol